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SConclusions: Complete revascularization after PCI was achieved in less than 50% of
pts with ACS, and was less frequent in DM compared to non-DM pts. Patients with
DM had higher rates of adverse outcomes compared to non-diabetics even when CR
was achieved, and the extent of IR was less of a prognostic factor in DM compared to
non-DM pts. Further strategies are required to improve the prognosis in high-risk
DM pts.
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Background: Prior studies suggest that younger women are at higher risk for major
adverse events following PCI; however, little is known about the association between
race and adverse outcomes in this population.
Methods: We evaluated 3797 women undergoing PCI in the NHLBI Dynamic
Registry and compared 1 year outcomes in African American (AA) women <50 years
(n¼101), AA women  50 years (n¼537), non-AA women < 50 years (n¼293), and
non-AA women  50 years (n¼2866) old.
Results: AA women were more likely to have hypertension, renal disease, and
concomitant severe non-cardiac disease compared to non-AA women. Irrespective of
race, younger women had less severe CAD angiographically. In-hospital adverse
events (death, MI, CABG, stroke) were comparable by race and age; however, young
AA women had the highest rate of MACE (young AA women: 28.6%, older AA
women: 18.4%, young non-AA women 27.6%, older non-AA women: 23.3%,
p¼0.02) at 1 year. While the rate of MI was lower (young AA women: 3.6%, older
AA women: 5.8%, young non-AA women 7.2%, older non-AA women: 5.4%,
p¼0.50), young AA women had a higher incidence of mortality than non-AA women
of similar age (young AA women: 5.8%, older AA women: 5.0%, young non-AA
women: 1.1%, older non-AA women: 5.8%, p¼0.009) at 1 year. Young women also
had higher rates of repeat revascularizations compared to older women, with young
AA women having the highest rate of CABG and young non-AA women having the
highest rate of repeat PCI at 1 year.One-Year Cumulative Event Rates for Women, By Race and Age
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% % % %
MACE1 28.6 18.4 27.6 23.3 0.03
Death 5.8 5.0 1.1 5.9 0.009
Myocardial
Infarction
3.6 5.8 7.2 5.4 0.50
Death or
Myocardial
Infarction
9.2 10.3 7.9 10.6 0.52
CABG 10.5 3.8 8.4 4.9 0.005
Repeat
PCI2
16.2 9.6 19.9 12.5 <0.001
CABG/
Repeat
PCI2
24.2 11.9 25.0 16.4 <0.001
Abbreviations MACE-major adverse cardiovascular events, CABG - coronary artery bypass graft
surgery, PCI - percutaneous coronary intervention
1Composite of death/myocardial infarction/CABG/repeat PCI
2 Excluding planned, staged PCI
JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Young AA women experienced higher rates of major adverse events
within 1 year of PCI, including a mortality rate four times higher than non-AA women
of similar age. It is plausible that our ﬁndings are due to a higher prevalence of non-
cardiac comorbidities; however, secondary prevention measures and practice patterns
post-PCI need to be explored to ensure this population is receiving optimal cardio-
vascular care following PCI.
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Background: Patients with signiﬁcant left anterior descending artery (LAD) disease,
particularly when the proximal segment is involved, considered to have an adverse
cardiac prognosis. It is reported that proximal LAD stenosis (P-LAD) have higher
rates of restenosis than that in other coronary segments after angioplasty, as well as
after stenting. However, the long term results of patients with P-LAD in complex
coronary artery disease (CAD) have not yet been adequately studied. Our study aimed
to ﬁnd out if the long term mortality of patients with P-LAD among the cohort with
three vessel diseases (TVD) and/or left main stenosis (LMS) higher than that without
P-LAD.
Methods: Patients undergoing elective PCI with drug eluting stents (DES) for TVD
and/or LMS have been included in this study. Important exclusion criteria were
previous coronary artery bypass surgery, high-risk acute coronary syndrome including
myocardial infarction. All-cause death was the primary endpoint of this analysis.
Survival of the patients was assessed by systematic patient contacts at one, two and
three years. In all patients we calculated SYNTAX score (SSc) to deﬁne the anatomic
complexity of coronary artery disease and logistic EuroScore (LES) to determine the
clinical risk. We used the Kaplan-Meier method to estimate the mortality. In addition,
we calculated adjusted and unadjusted hazard ratios by Cox models.
Results: 1,262 patients (mean age 67.7310.33 years, 24% female, median SSc
21.348.47) met the entry criteria. Median follow-up was 1197465.05 days. P-LAD
was present in 364 patients (28.84%). SSc in group with P-LAD was higher
(24.698.24 vs. 208.36, p<0.01). There was no signiﬁcant difference of one, two
and three-year mortality between the group with and without P-LAD (3.00.9 % vs.
2.90.6%; 5.01.2% vs. 5.20.7; 8.01.5% vs. 8.21.0%, p¼0.67; 0.64; 0.69).
Hazard ratio for mortality in the presence of P-LAD was 1.08 (95% CI 0.76 – 1.54,
p¼0.67). Even after adjustment for SSc and LES in multivariable analysis, P-LAD
was not predictive for mortality (adjusted HR 1.34 (0.94 – 1.94), p¼0.11).
Conclusions: P-LAD as single criterion has no signiﬁcant prognostic relevance in
patients with complex CAD.
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Background: Randomized controlled trials in patients with complex ischemic heart
disease (CIHD) suggest that patients with an intermediate/high SYNTAX score
beneﬁt from surgical revascularization. However its impact in decision making in
routine clinical practice is unknown. Using a multidisciplinary Heart Team (MHT) we
set out to evaluate therapeutic decision making in patients with complex IHD using
SYNTAX scores combined with Society of Thoracic Surgeons (STS)-derived clinical
variables.
Methods: MHT meetings consisting of interventional cardiologists and cardiac
surgeons were convened to discuss management of patients with CIHD. Angiographic
SYNTAX and STS risk were calculated and grouped according to risk scores Figure 1.
Final recommendations on revascularization were based on consensus that factored
angiographic and clinical characteristics
Results: 201 consecutive patients underwent MHT review. Mean(SD) STS risk
between groups showed; Group 1:1.4%(1.02), Group 2:7.4%(1.8), Group 3:1.5%(1.2)
and Group 4:9.9%(4.8) (p<0.0001). Mean(SD) SYNTAX score showed; group
1:15(4.8), Group 2:16(4.7), Group 3:29.7(6.1), and Group 4:32.4(6.1) (p<0.0001).
MHT recommendations are outlined in Tableacts/POSTER/Miscellaneous Coronary Topics B103
